In order to make effective decisions regarding em piric antibiotic therapy, surveillance of ordinary causative microorganisms in each NICU is required. In this issue of the journal, Wu et al report on their sur veillance study of neonatal sepsis in the NICU of a tertiary medical center in northern Taiwan. 18 They found that most neonates with early-onset sepsis were term infants, while very-low-birth-weight (VLBW) and preterm infants accounted for the majority of cases of late-onset sepsis. In ear ly-onset sepsis, the leading pathogens responsible were group B streptococci (GBS) and Escherichia coli. GBS were associated with more meningitis but lower mortality than E. coli. The most common pathogens involved in late-onset sepsis were co agulase-negative staphylococci and Candida. The sepsis-related mortality rates were higher for early-onset sepsis (10%) than late-onset sepsis (7%). They also suggested that GBS screening and intrapartum antibiotic prophyl (IAP) guidelines should be popularized in Taiwan to prevent neonatal early-onset sepsis. Although, this report provides us with information on the epidemiologic trends in this NICU, several issues must be addressed before general implementation of GBS screening and IAP guidelines in Taiwan.
The first such issue concerns the study pop ulation. This report is based on surveillance of neonates ad mitted to a single NICU. It is not a populationbased study, and whether or not its results can be applied to the general population in Taiwan is still unknown. A well-conducted pop ulation-based prospective study should answer this question.
The second issue is that this report reveals that most neonates with early-onset sepsis were term infants, while VLBW and preterm infants accounted for the majority of cases of late-onset sepsis. This is a very interesting finding and is quite different from those reported in a previous study. Benitz and associates performed a data analysis of risk factors for early-onset GBS sepsis from the 1970s to the 1990s to generate odds ratio estimates for several clinical factors. In their study, the neonatal risk fac tors predictive of early-onset GBS sepsis included prematurity (< 37 weeks' gestation), and low birth weight (< 2500 g), especially a birth weight < 1000 g. 19 From a practical point of view, it is not useful to demonstrate that most neonates with early-onset sepsis were term infants, while VLBW and preterm infants accounted for the majority of cases of late-onset sepsis. Instead, the identification of risk factors such as prematurity and low birth weight are more helpful in clinical decision-making.
The third issue relates to the cost-effectiveness analysis of generalized GBS screening and the application of IAP guidelines recommended by the CDC. Strategies based on screening for GBS colonization using rectovaginal cultures at 36 weeks' ges tation, or using a rapid test to screen for GBS colonization on presentation for delivery, combining intrapartum prophylaxis for selected mothers and postpartum prophylaxis for some of their infants, would require treatment of fewer patients and prevent more cases (78.4% or 80.1%, respectively) at lower costs. 20 Finally, even after widespread implementation of GBS screening and IAP guidelines in United States, there is a coincident finding that Gram-negative enteric bacteria have become the leading cause of EOS in preterm infants.
14,21 Again, we need to be careful about the generalized implementation of GBS screening and IAP guidelines; more studies are needed to evaluate their benefits/costs in the neonatal population.
